Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association
1 Department of Cardiology, University Hospital Gasthuisberg, Catholic University Leuven, Herestraat 49, 3000 Leuven, Belgium
2 Department of Cardiology, Heraklion University Hospital, 71100 Voutes, Heraklion Crete, Greece
* Corresponding author. E-mail address: hugo.ector{at}med.kuleuven.ac.be. (H.E.) or E-mail address: cardio{at}med.uoc.gr (P.V.)
The European pacemaker registry is based on data collected from European Pacemaker Identification Cards. A similar format was later developed for implantable cardioverter defibrillators (ICDs). According to national data collected in the registry, European practice appears to be characterized by an important degree of heterogeneity in implant rates of pacemakers, ICDs, and cardiac resynchronization therapy (CRT). Implant rates vary widely from country to country, even in adjacent countries with apparently similar populations. In 2005, the number of new implants of pacemakers ranged from 121 to 1134 per million and from 1.18 to 226 for ICDs across Europe. Overall, there remains an underuse of ICDs in Europe in comparison with what may be expected from epidemiological studies. There are increasing numbers of CRT devices being implanted with similar large discrepancies in implant rates between countries and variations in practice with respect to pacing only CRT devices (CRT-P) or their combination with an ICD (CRT-D).
Key Words: Atrioventricular block • Implantable cardioverter-defibrillator • Pacemaker • Registry • Sinoatrial node disease
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Cabrera-Bueno, J. Fernandez-Pastor, M. J. Molina-Mora, J. Alzueta, J. L. Pena-Hernandez, A. Barrera, and E. de Teresa-Galvan Combined resynchronization therapy and automatic defibrillator in advanced non-ischaemic heart failure: the importance of QRS width Europace, November 6, 2009; (2009) eup348v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Korantzopoulos, K. P. Letsas, G. Grekas, and J. A. Goudevenos Pacemaker dependency after implantation of electrophysiological devices Europace, September 1, 2009; 11(9): 1151 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.S. Cunnington, C.J. Plummer, and J.M. McComb Delays and adverse clinical outcomes associated with unrecognized pacing indications QJM, July 1, 2009; 102(7): 485 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boriani, M. Biffi, A. Marziali, I. Diemberger, and C. Martignani A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance Europace, January 1, 2009; 11(1): 1 - 3. [Full Text] [PDF]
|
|